Efalizumab - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Withdrawn drug Genentech brand Hoffmann-La Roche brand owl:NamedIndividual Immunosuppressant Monoclonal antibody Therapeutic monoclonal antibody Merck brand Recombinant protein
rdfs:label	Efalizumab
owl:sameAs	dbr:Efalizumab
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Roche http://en.wikipedia.org/wiki/Category:Withdrawn_drugs http://en.wikipedia.org/wiki/List_of_withdrawn_drugs http://en.wikipedia.org/wiki/Category:Merck_brands http://en.wikipedia.org/wiki/Genentech http://en.wikipedia.org/wiki/List_of_drugs:_E%E2%80%93El http://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies http://en.wikipedia.org/wiki/Psoriatic_onychodystrophy http://en.wikipedia.org/wiki/Category:Immunosuppressants http://en.wikipedia.org/wiki/Category:Monoclonal_antibodies http://en.wikipedia.org/wiki/Category:Genentech_brands http://en.wikipedia.org/wiki/Category:Hoffmann-La_Roche_brands http://en.wikipedia.org/wiki/Category:Recombinant_proteins http://en.wikipedia.org/wiki/List_of_recombinant_proteins
skos:prefLabel	Efalizumab
skos:altLabel	Raptiva efalizumab
clgo:alternativeName	Raptiva
clgo:casNumber	214745-43-4
clgo:chEMBL	1201575
clgo:drugbank	DB00095
clgo:fdaUniiCode	XX2MN88N5D

About: clgr:Efalizumab